|
Characteristics
|
FPGS SNP rs1544105
|
p-value*
|
|---|
|
CC
|
CT + TT
|
|---|
|
genotype
|
genotype
|
|---|
|
Gender
| | |
1.000
|
|
Male
|
9 (62.3)
|
95 (63.3)
|
|
Female
|
5 (35.7)
|
55 (36.7)
|
|
Age (years)
| | |
0.336
|
|
<1
|
0
|
0
|
|
1-9
|
13 (92.9)
|
123 (82.0)
|
|
≥10
|
1 (7.1)
|
27 (18.0)
|
|
Treatment group
| | |
0.797
|
|
SR
|
4 (28.6)
|
58 (38.7)
|
|
MR
|
8 (57.1)
|
73 (48.7)
|
|
HR
|
2 (1.3)
|
19 (12.6)
|
|
WBC (109/L)
| | |
0.710
|
|
<50
|
11 (78.6)
|
125 (83.3)
|
|
≥50
|
3 (21.4)
|
25 (16.7)
|
|
TEL-AML1
| | |
0.770
|
|
Positive
|
3 (21.4)
|
38 (25.3)
|
|
Negative
|
11 (78.6)
|
112 (74.7)
|
|
E2A-PBX1
| | |
1.000
|
|
Positive
|
1 (7.1)
|
15 (10.0)
|
|
Negative
|
13 (92.9)
|
135 (90.0)
|
|
BCR-ABL
| | |
0.141
|
|
Positive
|
2 (14.3)
|
6 (4.0)
|
|
Negative
|
12 (85.7)
|
144 (96.0)
|
|
MLL-AF4
| | |
1.000
|
|
Positive
|
0
|
1 (0.6)
|
|
Negative
|
14 (100.0)
|
149 (99.4)
|
|
Prednisone response
| | |
0.164
|
|
Good
|
1 (7.1)
|
1 (0.6)
|
|
Poor
|
13 (92.9)
|
149 (99.4)
|
|
CNS involvement
| | |
1.000
|
|
Absent
|
14 (100.0)
|
148 (98.7)
|
|
Present
|
0
|
2 (1.3)
|
- *Data were calculated by χ2 test. WBC, white blood cell count; SR, standard-risk; MR, medium-risk; HR, high-risk; CNS, central nervous system.
